Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
Rallybio to acquire Candid Therapeutics
Nia JulianMarch 9, 2026
Facebook0 Twitter Pinterest0 0 Likes
Next

Gilead to buy Arcellx in $7.8B wager on multiple myeloma cell therapy

Nia JulianFebruary 24, 2026

© 2020 Solasta Ventures. All Rights Reserved.